The interaction of radiolabeled factor VII (FVII) and factor VIIa (FVIIa) with endotoxin-stimulated endothelial cells (EC), known to express tissue factor (TF), and unstimulated EC was studied. FVII/FVIIa binding to EC-monolayers was saturable within 4.5-6 h, reversible, temperature and calcium dependent on both, endotoxin-stimulated and on unstimulated EC. Upon 2 h of incubation on EC, FVII was partially converted to FVIIa in the absence of protease inhibitors. The affinity of this binding was Kd = 45.4 ± 18.7 nM with a calculated number of binding sites Bmax = 3.75 ± 0.31 × 106 molecules/cell. In addition to unlabeled FVII and FVIIa, other vitamin K-dependent proteins reduced binding of [125I]-FVII/FVIIa to about 60-70%, and this type of common binding site for vitamin K-dependent proteins revealed a Kd = 32.2 ± 5.6 nM and a Bmax = 3.03 ± 0.14 × 106 molecules/cell. Moreover, in the presence of 1 μM prothrombin to suppress common binding sites, only on endotoxin-stimulated EC additional inhibition of FVII/FVIIa binding was achieved by anti-TF antibodies. The characteristics of the FVII/FVIIa-TF interaction with a Kd = 17.2 ± 5.2 nM and a Bmax = 342,000 ± 1,100 binding sites/cell revealed a similar saturation kinetics in radioligand binding and in functional factor X activation within 90-120 min. These data indicate the presence of at least two independent binding sites for FVII/FVIIa on stimulated EC of which about 10% are TF specific. The existence of binding sites common for vitamin K-dependent proteins on both types of EC may improve the availability of FVII/FVIIa once EC become stimulated and express TF on their surface.
References
1
Colucci M,
Balconi G,
Lorenzet R,
Pietra A,
Locati D,
Donati MB,
Semeraro N.
Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893-1896
2
Brox JH,
Osterud B,
Björklid E,
Fenton JW.
Production and availability of thromboplastin in endothelial cells: the effect of thrombin, endotoxin and platelets. Br J Haematol 1984; 57: 239-246
7
Warr TA,
Rao LVM,
Rapaport SI.
Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481-1489
11
Bach R,
Gentry R,
Nemerson Y.
Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine. Biochemistry 1986; 25: 4007-4020
13
Sakai T,
Lund-Hansen T,
Paborsky L,
Pedersen AH,
Kisiel W.
Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation. J Biol Chem 1989; 264: 9980-9988
15
Osterud B,
Björklid E.
Human factor VII associated with endotoxin-stimulated monocytes in whole blood. Biochem Biophys Res Commun 1982; 108: 620-626
16
Ruf W,
Edgington TS.
Two sites in the tissue factor extra-cellular domain mediate the recognition of the ligand factor VIIa. Proc Natl Acad Sci 1991; 88: 8430-8434
17
Fraker PJ,
Speck Jr JC.
Protein and cell membrane iodination with sparingly soluble chloramine, 1,3,4,6-tetrachloro-3a,6a-diphenyl glycouril. Biochem Biophys Res Commun 1978; 80: 849-857
18
Preissner KT,
Wassmuth R,
Müller-Berghaus G.
Physicochemical characterization of human S-protein and its function in the blood coagulation system. Biochem J 1985; 231: 349-355
19
Preissner KT,
Delvos U,
Müller-Berghaus G.
Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism. Biochemistry 1987; 26: 2521-2528
20
Bradford MM.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
21
Tanaka H,
Janssen B,
Preissner KT,
Müller-Berghaus G.
Purification of glycosylated apoprotein of tissue factor from human brain and inhibition of its procoagulant activity by a specific antibody. Thromb Res 1985; 40: 745-756
22
Born VJJ,
Ram IE,
Alderkamp GHJ,
Reinaldapoot HH,
Bertina RM.
Application of factor VII-sepharose affinity chromatography in purification of human tissue factor apoprotein. Thromb Res 1986; 42: 635-643
28
Merill CR,
Switzer RC,
Van Keuren ML.
Trace polypeptides in cellular extracts and human body fluids detected by two-dimensional electrophoresis and highly sensitive silver stain. Proc Natl Acad Sci USA 1979; 76: 4335-4339
30
Sakai T,
Kisiel W.
Binding of human factor X and Xa to HepG2 and J82 human tumor cell lines. Evidence that FXa binds to tumor cells independent of factor Va. J Biol Chem 1990; 265: 9105-9113
32
Rodgers GM,
Shuman MA.
Characterisation of the interaction between factor Xa and bovine aortic endothelial cells. Biochim Biophys Acta 1985; 844: 320-329
35
Toomey JR,
Smith KJ,
Stafford DW.
Localization of the human tissue factor recognition determinant of human factor VIIa. J Biol Chem 1991; 266: 19198-19202
36
Ruf W,
Kalnik MW,
Lund-Hansen T,
Edgington TS.
Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. J Biol Chem 1991; 266: 15719-15725
37
Sakai T,
Lund-Hansen T,
Thim L,
Kisiel W.
The ϒ-carboxyglutamic acid domain of human factor VIIa is essential for its interaction with cell surface tissue factor. J Biol Chem 1990; 265: 1890-1894
38
Rodgers GM,
Broze Jr GJ,
Shuman MA.
The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation. Blood 1984; 63: 434-438
39
Nemerson Y,
Repke D.
Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor. Thromb Res 1985; 40: 351-358
40
Rao LVM,
Rapaport SI.
Activation of factor VII bound to tissue factor: A key early step in the tissue factor pathway of coagulation. Proc Natl Acad Sci USA 1988; 85: 6687-6691
41
Broze GJ,
Warren LA,
Novotny WF,
Higuchi DA,
Girard JJ,
Miletich JP.
The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood 1988; 71: 335-343